RT @CochraneLibrary: Oral Janus kinase inhibitors (tofacitinib) for maintenance of remission in ulcerative colitis https://t.co/r9qFqA0mhB…
Oral Janus kinase inhibitors (tofacitinib) for maintenance of remission in ulcerative colitis https://t.co/r9qFqA0mhB #IBD High‐certainty evidence found in this Cochrane systematic review.
https://t.co/c25piDsPAU Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis Tofacitinib en mantenimiento de la remisión en CU. Meta análisis de Cochrane
Oral Janus kinase inhibitors (tofacitinib) for maintenance of remission in ulcerative colitis https://t.co/aK8rj15HNP #IBD High‐certainty evidence found in this Cochrane systematic review. https://t.co/k4XIlGQkC4
High certainty evidence for effectiveness and appear safe, but vs placebo - trials are needed vs standard therapy?
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. https://t.co/6zKlonggyq
New article: Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. https://t.co/37vb2EGaAg #melanoma #oncology